Varicose veins are abnormal and enlarged blood vessels caused by weakening walls of the veins due to this the veins appear as a swollen, twisted, cluster of blue or purple under the skin. Varicose veins are caused by the ineffective blood flow in the lower limbs.
Available treatments for varicose veins have improved in the last few years. Most of the treatments include minimally invasive techniques such as radiofrequency ablation and laser therapies. Due to the risk of infections associated with invasive surgeries, noninvasive procedures have replaced surgical vein stripping methods.
The market is driven by increased incidences of varicose veins problem, rise in geriatric population, technological advancements in the treatment, and government initiatives.
Technological advancements include new treatment procedures that are less-invasive due to the risk of infections associated with invasive surgeries. Surgery in case of the varicose veins has been largely replaced by noninvasive options.
The high cost of varicose veins treatment procedures, lack of trained vascular surgeons, and inconsistent reimbursement scenario are going to restrain the market in the forecast period.
The Varicose Veins Treatment Market is segmented by treatment type as Surgical Treatments and Non-Surgical Treatments.
By product, the market is segmented as Ablation Devices, Sclerotherapy Injection, Venous Closure Products, and Others, Ablation Devices are further bifurcated into Radiofrequency Ablation Devices and Laser Ablation Devices, and by the end-user, the market is segmented into Hospitals, Clinics, and Ambulatory Centers.
By treatment, type Sclerotherapy is expected to account for the largest market share during the forecast period. Sclerotherapy is a non-invasive technique in which a foam Sodium Tetradecyl Sulfate (STS) is injected in the veins.
Geographically, the Varicose Veins Treatment Market is divided into North America, Europe, South America, Asia-Pacific, and the Middle East and Africa.
North America region has a dominant position in the market due to high disposable income, advanced healthcare infrastructure, and introduction of advanced technology.
Asia-Pacific is expected to grow at the highest CAGR over the period of forecast due to high population base, development in healthcare infrastructure, and increase in the geriatric population. According to the Journal of Evolution of Medical and Dental Sciences (JEMDS), the prevalence of varicose veins accounted for around 10% in India.
Some of the major key players in the market are Medtronic, Lumenis, Alma Lasers Ltd., Angiodynamics, Inc., Biolitec AG, BTG PLC, Energist Ltd., Sciton Inc., WONTECH Co., Ltd., and Syneron. In the varicose veins treatment market, Medtronic plc holds the leadership position due to production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
